Latest news

CONNECT Seminar on Clinical Decision Support Systems

Clinical Decision Support Systems: useful for what and for whom? In his introduction, Eivind Hovig, Professor at the Centre for...

CONNECT's partner, Eli Lilly & Company, is now part of the IMPRESS study

CONNECTs partner Eli Lilly & Company is now offering participants of the IMPRESS study a new and promising medicine.

CONNECT seminar: The new EU regulations on IVDR – how to be prepared?

The winner of King Olav V’s Prize for Cancer Research 2021 is Bjørn Tore Gjertsen

This year’s King Olav V’s Prize for Cancer Research will go to Professor Bjørn Tore Gjertsen, one of CONNECT’s Steering Committee...

Opinion piece (only available in Norwegian): Nye kreftbehandlinger krever nye samarbeidsformer

Norge står i en internasjonal særstilling for å kunne samarbeide godt i helsesektoren, men det krever at politikerne tør å satse, skriver...

CONNECT at Arendalsuka

Connect had the pleasure of participating at Arendalsuka. Here you can find the debates and conversations we had during the event....

Novartis enters IMPRESS

One of the largest pharmaceutical companies enters the precision cancer study IMPRESS in Norway.

New partners join precision medicine consortium

Five new partners have joined CONNECT.

CONNECT educational seminar

Watch the engaging presentations from the first CONNECT educational seminar for the Norwegian oncology community. CONNECT Working Group 1...